International Symposium Promotes Discussion On Latest Research
RYE, NY, May 19, 2004 -- The 12th International Symposium of the Active Hexose Correlated Compound (AHCC) and Genistein Combined Polysaccharide (GCP) Research Associations is scheduled for July 24-25, 2004, in Sapporo, Japan. The focus of the Symposium is to discuss new AHCC and GCP research and developments over the past year. Approximately 350 medical doctors from around the world are expected to attend this year's event.
The AHCC and GCP Research Associations were established in the U.S. to promote clinical research of these functional foods and to educate healthcare professionals and scientists of their benefits. For the third consecutive year, the Symposium will be co-sponsored by The Foundation for Basic Research of Oncology (the association authorized by the Japanese Ministry of Health and Welfare as an official foundation to execute and to support basic research projects on cancer) and Amino Up Chemical Co., Ltd., headquartered in Sapporo, Japan.
"As the Symposium continues to grow in size and context, the benefits of AHCC and GCP are becoming more well known and accepted," stated Fred Pescatore, M.D., M.P.H., medical director of the U.S. AHCC Research Association and founder of Partners in Integrative Medicine. "The worldwide commitment to advance the science supporting AHCC and GCP further is apparent each year at the Symposium, as several doctors collaborate to share their latest findings and to discuss applications of these novel ingredients."
AHCC is derived from a highly specialized manufacturing process that relies on the hybridization of several species of mushrooms cultivated in Japan.
According to industry analysts in Japan, over 700 hospitals and medical clinics recommend AHCC to patients in that country as part of an immune support regimen.
GCP is produced by a special soybean fermentation technique involving isoflavone extracts and medicinal mushrooms. GCP contains rich levels of isoflavone aglycones, especially Genistein, as well as polysaccharides from Basidiomycetes mushrooms. Isoflavone glycosides are transformed into aglycones using b-glucosidase-producing basidiomycetes via an innovative Japanese technology. GCP is well tolerated by the body with no known serious side effects.
Further details of the 12th International AHCC and GCP Research Associations Symposium will be available as the event nears. For more information on the individual Research Associations visit www.AHCCresearch.com and www.GCPresearch.com. The Symposium is open to members of the media. If you are interested in attending or would like more press information, contact Natalie Taylor at email@example.com or 801.538.0777 ext.107.
# # #